Search Results - Gargano, M
- Showing 1 - 3 results of 3
-
1
-
2
Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3–1,6 beta glucan pathogen associated molecular pattern, in healthy volun... by Halstenson, C. E., Shamp, T., Gargano, M. A., Walsh, R. M., Patchen, M. L.
Published 2016Text -
3
A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3–1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherap... by Thomas, M., Sadjadian, P., Kollmeier, J., Lowe, J., Mattson, P., Trout, J. R., Gargano, M., Patchen, M. L., Walsh, R., Beliveau, M., Marier, J. F., Bose, N., Gorden, K., Schneller, F.
Published 2017Text